Track 12: Cancer Genomics & Metabolomics


Oncogenomics is a sub-field of genomics that characterizes cancer-associated or cancer related genes. It focuses mainly on genomic, epigenomic and transcript alterations in cancer. The main concept and idea of oncogenomics is to check new group of oncogenes or tumor suppressor genes that may give new areas of research into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The Gleevec, Herceptin and Avastin are the targeted cancer therapies which gave a new way for oncogenomics to elucidate new targets for cancer treatment. The metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism that are the end biology.


    Related Conference of Track 12: Cancer Genomics & Metabolomics

    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    August 08-09, 2024

    20th World Congress on Healthcare & Technologies

    London, UK
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Paris, France
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France
    November 11-12, 2024

    9th Global Summit on Midwifery and Womens Health

    Dubai, UAE
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    November 25-26, 2024

    4th International conference on Healthcare Summit

    Bali, Indonesia
    November 28-29, 2024

    World Vaccine Meet 2024

    Bali, Indonesia
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France

    Track 12: Cancer Genomics & Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in